MxP Partners

About The Fund

MxP Partners LLP is a mid-market private investment office that specializes in sourcing and managing investments in businesses with high potential, delivering long-term value creation for its investors. Established in 2006 by Michael George after the sale of Weetabix, MxP Partners has developed into a sector-agnostic equity firm. The company's partners boast significant experience and provide investors with access to top-ranking performance, lower fees, enhanced control, and transparency. MxP Partners shows commitment to building on their mid-market track record by executing a number of private equity transactions with substantial control. They operate on a transaction-by-transaction basis, ensuring deep engagement with each investment. They focus on large, growing sectors with opportunities that can be exploited over the long term, aligning with talented management teams in businesses reaching towards an EBITDA of £10m and above. Their mid-market focus targets enterprise values between £50m to £300m which include buyouts, carve-outs, MBOs, and growth capital investments. MxP Partners also offers co-investment opportunities to invest alongside them, extending a clear alignment of interest with co-investors. The firm's strategy targets several defensible growth sectors with strong market tailwinds, such as consumer grain-related products, health and wellness, pet products, and IT services, including business process outsourcing, cloud infrastructure, and healthcare-related software, among others. With a thematic strategic focus, MxP targets growth dynamics within these sectors, and looks for proprietary opportunities, avoiding widely marketed auctions. MxP commits to integrity and quality in its investments, underpinned by solid professional relationships based on trust. The firm's track record shows a total of £920.0m invested, with a 3.8x return on realized investments, and an average investment size of £20.0m over 47 investments.